Balaglitazone (Standard)
Balaglitazone (Standard) is the analytical standard of Balaglitazone. This product is intended for research and analytical applications. Balaglitazone is a selective partial PPARγ agonist with an EC50 of 1.351 μM for human PPARγ.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 98%
- CAS 番号: 199113-98-9
- 分子式: C20H17N3O4S
- 分子量:395.43
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-15655
GW1929PPARγ Agonist -
HY-13956
PioglitazonePPARγ Agonist -
HY-16086
Balaglitazone -
HY-16578
GW9662PPARγ Antagonist -
HY-14601
Pioglitazone hydrochloridePPARγ Agonist -
HY-16995
Pirinixic acidPPAR Agonist -
HY-17444
TesaglitazarPPARα/γ Agonist -
HY-B0637
BezafibratePPAR Agonist -
HY-17356
Fenofibrate -
HY-13861
GW7647PPAR Agonist -
HY-17386
RosiglitazonePPARγ Agonist -
HY-50935
TroglitazonePPARγ Agonist
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 199113-98-9
-
分子量 395.43
-
分子式 C20H17N3O4S
-
SMILES
O=C(N1)SC(CC2=CC=C(OCC(N3C)=NC4=C(C=CC=C4)C3=O)C=C2)C1=O
-
別名
DRF 2593 (Standard); NN 2344 (Standard)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Larsen PJ, et al. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone. Eur J Pharmacol. 2008 Oct 31;596(1-3):173-9. [Content Brief]
[2]. Yousefi B, et al. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells. Tumour Biol. 2017 Oct;39(10):1010428317716501. [Content Brief]
[3]. Henriksen K, et al. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats. Eur J Pharmacol. 2009 Aug 15;616(1-3):340-5. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Balaglitazone (Standard) 関連分類
HY-16086R 関連分類
Powered by Bioz